Jefferies is out with its report today on Thermo Fisher Scientific TMO, raising its PT from $66 to $68.
In a note to clients, Jefferies writes, "TMO's 1Q11 EPS of $0.92 was $0.04 ahead of consensus on stronger revenue growth and better profit trends. We are raising our 2011 EPS forecast to $4.10 (from $4.00) to reflect the 1Q11 upside (+$0.05) and to account for anticipated DNEX-related contribution. Our PT moves to $68 (from $66) on higher cash flow forecasts."
Jefferies maintains Buy on TMO.
Shares of TMO closed Wednesday at $59.80.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Posted In: Analyst ColorPrice TargetAnalyst RatingsHealth CareJefferiesLife Sciences Tools & Servicesthermo fisher scientific
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in